Ankündigung • Feb 04
Borregaard ASA Proposes Ordinary Dividend for 2025, Payable on 27 April 2026 The Board of Directors of Borregaard ASA at a meeting on 3 February 2026 decided to propose an ordinary dividend for 2025 of NOK 4.75 per share to the Annual General Meeting. Dividend payment is estimated at NOK 474 million. The exact amount will depend on the number of treasury shares held at the date of the Annual General Meeting. No dividend will be paid on treasury shares held by the Borregaard Group. Provided that the traded shares are subject to ordinary settlement in the Norwegian Securities Register (VPS), shares acquired up to and including 16 April 2026 will carry the right to receive dividends, whereas shares that are acquired on and after 17 April 2026 will not carry the right to receive dividends. Subject to the decision of the Annual General Meeting, the dividend will be paid on 27 April 2026 to shareholders registered in the company’s shareholders’ register as evidenced in a transcript as of 20 April 2026. The share will be quoted ex dividend on 17 April 2026. The Annual General Meeting of Borregaard ASA will be held on Thursday 16 April 2026 at 1 p.m. (13:00 CEST) in Sarpsborg as a digital meeting. Ankündigung • Sep 27
Borregaard Announces NOK 15 Million Award for Biomer Project to Develop Bio-Based Alternatives to Polycarboxylates The Norwegian Research Council has awarded NOK 15 million to support Borregaard’s innovation initiative, Biomer. The project aims to develop bio-based alternatives to polycarboxylates – fossil-based polymers commonly used in agriculture, industry, and household products. Polycarboxylates are known for their persistence in the environment and high carbon footprint. Through Biomer, Borregaard will develop new ways to turn Norwegian bioresources into greener polymers designed to replace these fossil-based materials. The project will leverage Borregaard’s advanced biorefinery in Sarpsborg and its expertise in wood chemistry to deliver sustainable solutions with significantly lower environmental impact. Ankündigung • Jun 13
Borregaard ASA Announces Change in Group Executive Management, Effective August 1, 2025 Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August. Bakke currently serves as Director of Investor Relations and has previously held the position of Energy Director at Borregaard. Prior to joining the company in 2019, he held senior leadership roles at Norsk Hydro, where he was responsible for global energy market operations. He holds an MSc in Industrial Economics and Technology Management from the Norwegian University of Science and Technology (NTNU). Borregaard will initiate a process to appoint a new Director of Investor Relations. In the interim, CFO Per Bjarne Lyngstad will assume the responsibility from 1 August. Ankündigung • Jan 29
Borregaard Asa Proposes Ordinary Dividend for 2024, Payable on 23 April 2025 At a meeting on 30 January 2024, the Board of Directors of Borregaard ASA decided to propose to the Annual General Meeting an ordinary dividend for 2024 of NOK 4.25 per share. Ex-date: 11 April 2025. Record date: 14 April 2025. Payment date: 23 April 2025. Date of approval: 10 April 2025. Ankündigung • Sep 20
Borregaard ASA, Annual General Meeting, Apr 10, 2025 Borregaard ASA, Annual General Meeting, Apr 10, 2025. Ankündigung • Jan 31
Borregaard ASA Proposes Cash Dividend for 2023, Payable on 22 April 2024 At a meeting on 30 January 2024, the Board of Directors of Borregaard ASA decided to propose to the Annual General Meeting an ordinary dividend for 2023 of NOK 3.75 per share. Ex-date: 12 April 2024. Record date: 15 April 2024. Payment date: 22 April 2024. Date of approval: 11 April 2024. Ankündigung • Nov 29
Borregaard ASA (OB:BRG) commences an Equity Buyback Plan for 10% of its issued share capital, under the authorization approved from April 18, 2023. Borregaard ASA (OB:BRG) commences share repurchases on November 20, 2023, under the program mandated by the shareholders in the Annual General Meeting held on April 18, 2023. As per the mandate, the company is authorized to repurchase up to a total nominal value of NOK 10 million, corresponding to 10% of the share capital. The shares will be repurchased at a price not more than NOK 400 per share and no less than NOK 1 per share. The company may repurchase and dispose of its own shares to fulfil its incentive schemes. The repurchases will be used for amortization. The plan will be valid up to the 2024 Annual General Meeting, but no later than June 30, 2024.
On November 17, 2023, the company announced its intention of repurchasing 200,000 shares of its outstanding common stock. The repurchase of shares will be conducted in a period from November 20, 2023, up to and including December 20, 2023 at the latest. Valuation Update With 7 Day Price Move • Feb 09
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to kr184, the stock trades at a forward P/E ratio of 20x. Average forward P/E is 20x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 92% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at kr147 per share. Reported Earnings • Feb 05
Full year 2022 earnings released: EPS: kr8.95 (vs kr6.95 in FY 2021) Full year 2022 results: EPS: kr8.95 (up from kr6.95 in FY 2021). Revenue: kr6.88b (up 19% from FY 2021). Net income: kr892.0m (up 29% from FY 2021). Profit margin: 13% (up from 12% in FY 2021). The increase in margin was driven by higher revenue. Revenue is forecast to grow 1.2% p.a. on average during the next 3 years, compared to a 1.6% growth forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Ankündigung • Feb 02
Borregaard ASA Proposes Ordinary Dividend for 2022, Payable on 27 April 2023 At a meeting on 1 February 2023, the Board of Directors of Borregaard ASA decided to propose to the Annual General Meeting an ordinary dividend for 2022 of NOK 3.25 per share. Ex-date: 19 April 2023; Record date: 20 April 2023; Payment date: 27 April 2023; Date of approval: 18 April 2023. Recent Insider Transactions • Dec 15
Independent Chairman recently bought kr95k worth of stock On the 9th of December, Helge Aasen bought around 600 shares on-market at roughly kr159 per share. This transaction amounted to 15% of their direct individual holding at the time of the trade. In the last 3 months, there was an even bigger purchase from another insider worth kr217k. This was Helge's only on-market trade for the last 12 months. Recent Insider Transactions • Nov 03
Director recently bought kr217k worth of stock On the 1st of November, John Ulvan bought around 2k shares on-market at roughly kr145 per share. This transaction amounted to 75% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought kr1.5m more in shares than they have sold in the last 12 months. Valuation Update With 7 Day Price Move • Oct 28
Investor sentiment improved over the past week After last week's 17% share price gain to kr148, the stock trades at a forward P/E ratio of 16x. Average forward P/E is 16x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 76% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at kr206 per share. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: kr2.40 (vs kr2.12 in 3Q 2021) Third quarter 2022 results: EPS: kr2.40 (up from kr2.12 in 3Q 2021). Revenue: kr1.75b (up 23% from 3Q 2021). Net income: kr239.0m (up 13% from 3Q 2021). Profit margin: 14% (down from 15% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 8.8% decline forecast for the Chemicals industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 17% share price decline to kr126, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 17x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 32% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at kr81.28 per share. Reported Earnings • Jul 16
Second quarter 2022 earnings released: EPS: kr2.52 (vs kr2.34 in 2Q 2021) Second quarter 2022 results: EPS: kr2.52 (up from kr2.34 in 2Q 2021). Revenue: kr1.74b (up 15% from 2Q 2021). Net income: kr252.0m (up 8.2% from 2Q 2021). Profit margin: 14% (down from 15% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 12% compared to a 16% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 17% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jul 14
Investor sentiment deteriorated over the past week After last week's 19% share price decline to kr150, the stock trades at a forward P/E ratio of 18x. Average forward P/E is 19x in the Chemicals industry in the United Kingdom. Total returns to shareholders of 71% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at kr242 per share. Upcoming Dividend • Apr 01
Upcoming dividend of kr5.00 per share Eligible shareholders must have bought the stock before 08 April 2022. Payment date: 21 April 2022. Payout ratio is a comfortable 40% and this is well supported by cash flows. Trailing yield: 1.6%. Lower than top quartile of British dividend payers (4.7%). Lower than average of industry peers (2.6%). Reported Earnings • Mar 19
Full year 2021 earnings: Revenues exceed analyst expectations Full year 2021 results: Revenue: kr5.81b (up 9.0% from FY 2020). Net income: kr692.0m (up 59% from FY 2020). Profit margin: 12% (up from 8.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.7%. Over the next year, revenue is forecast to grow 3.1% compared to a 11% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has increased by 30% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Feb 08
Full year 2021 earnings: EPS in line with analyst expectations despite revenue beat Full year 2021 results: EPS: kr6.95 (up from kr4.37 in FY 2020). Revenue: kr5.81b (up 9.0% from FY 2020). Net income: kr692.0m (up 59% from FY 2020). Profit margin: 12% (up from 8.2% in FY 2020). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 4.7%. Over the next year, revenue is forecast to grow 8.5% compared to a 3.1% decline forecast for the industry in the United Kingdom. Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Recent Insider Transactions • Dec 08
Insider recently bought kr710k worth of stock On the 6th of December, Kristin Misund bought around 10k shares on-market at roughly kr70.95 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought kr3.0m more in shares than they have sold in the last 12 months. Recent Insider Transactions • Nov 27
General Counsel recently sold kr268k worth of stock On the 25th of November, Rolf Heggen sold around 1k shares on-market at roughly kr223 per share. This was the largest sale by an insider in the last 3 months. Despite this recent sale, insiders have collectively bought kr2.3m more than they sold in the last 12 months. Recent Insider Transactions • Aug 03
General Counsel recently bought kr1.4m worth of stock On the 29th of July, Rolf Heggen bought around 15k shares on-market at roughly kr91.56 per share. This was the largest purchase by an insider in the last 3 months. Insiders have collectively bought kr461k more in shares than they have sold in the last 12 months. Reported Earnings • May 01
First quarter 2021 earnings released: EPS kr1.46 (vs kr1.02 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: kr1.42b (up 3.4% from 1Q 2020). Net income: kr146.0m (up 43% from 1Q 2020). Profit margin: 10% (up from 7.4% in 1Q 2020). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings. Reported Earnings • Mar 26
Full year 2020 earnings released: EPS kr4.37 (vs kr4.18 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr5.33b (up 5.2% from FY 2019). Net income: kr436.0m (up 4.6% from FY 2019). Profit margin: 8.2% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 35% per year, which means it is well ahead of earnings. Recent Insider Transactions • Mar 25
Insider recently bought kr1.4m worth of stock On the 18th of March, Gisle Johansen bought around 15k shares on-market at roughly kr94.06 per share. This was the largest purchase by an insider in the last 3 months. Despite this recent purchase, insiders have collectively sold kr205k more in shares than they bought in the last 12 months. Is New 90 Day High Low • Feb 18
New 90-day high: kr167 The company is up 26% from its price of kr132 on 20 November 2020. The British market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 13% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr167 per share. Reported Earnings • Feb 05
Full year 2020 earnings released: EPS kr4.36 (vs kr4.17 in FY 2019) The company reported a solid full year result with improved earnings and revenues, although profit margins were flat. Full year 2020 results: Revenue: kr5.33b (up 5.2% from FY 2019). Net income: kr436.0m (up 4.6% from FY 2019). Profit margin: 8.2% (in line with FY 2019). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 31% per year, which means it is well ahead of earnings. Analyst Estimate Surprise Post Earnings • Feb 05
Revenue beats expectations Revenue exceeded analyst estimates by 2.2%. Over the next year, revenue is expected to shrink by 1.2% compared to a 11% decline forecast for the Chemicals industry in the United Kingdom. Is New 90 Day High Low • Feb 05
New 90-day high: kr167 The company is up 22% from its price of kr137 on 06 November 2020. The British market is up 12% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr162 per share. Is New 90 Day High Low • Jan 14
New 90-day high: kr147 The company is up 4.0% from its price of kr142 on 16 October 2020. The British market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 10.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is kr162 per share. 
